Skip to main content
Find a DoctorGet Care Now
Skip to main content
Search icon magnifying glass

Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Health’s Gayle Capozzalo recipient of the Gold Medal Award for 2017 by American College of Healthcare Executives

Thursday, February 16, 2017

New Haven, CT –February 16, 2017—Gayle L. Capozzalo, chief strategy officer for strategy and system development, Yale New Haven Health, has been awarded the Gold Medal Award  for 2017 by the American College of Healthcare Executives (ACHE). Capozzalo has served as the executive vice president of Strategy and System Development for Yale New Haven Health System (YNHHS) for over 18 years. YNHHS is an integrated delivery network with revenues in excess of $3.4 billion.

Capozzalo served as ACHE Chairman from 2012 to 2013, on the Board of Governors from 2007 to 2010 and ACHE’s Council of Regents from 2004 to 2007. Capozzalo is also a member of the Institute for Healthcare Improvement and serves on its audit and compliance committee. 

“Gayle Capozzalo’s leadership has been integral to Yale New Haven Health’s growth and performance for over 18 years,” said Marna P. Borgstrom, CEO, Yale New Haven Health and Yale New Haven Hospital.  “Gayle is a true leader in every organization or group she touches.  She has ably led strategy at our Health System and has been an architect of our strategic growth.   In our State, she has served on several boards including Connecticut Public TV and Planned Parenthood.  Additionally she has served on the national level in many volunteer leadership roles and as an opinion leader on the evolution of health care.   Gayle leads by example and champions the importance of women in healthcare.  She is a great colleague and friend.” 

During her tenure at YNHHS, Capozzalo’s leadership has overseeing tremendous growth, streamlining of expenses and implementing major improvements in technology and services to the community. In ACHE alone, she has been an active leader at the local and national level throughout her career. Her numerous roles have included serving as chapter president, regent and governor, culminating in an appointment to chairman in 2012. In addition, she is actively involved with three community organizations, serving on the board of two. She holds three faculty positions and serves on the boards of numerous healthcare organizations.
The Gold Medal Award—ACHE’s highest honor bestowed on outstanding leaders—identifies Fellows of the American College of Healthcare Executives who best exemplify leadership at the organizational, local, state/provincial and national levels. The Gold Medal Award recognizes individuals who go beyond the confines of their own organization to continually contribute to the improvement of healthcare services and community health.

Capozzalo will receive her award and recognition at the ACHE awards Monday, March 27, 2017, at the Opening Session during ACHE’s 60th Congress on Healthcare Leadership.

Similar Articles

12/9/2025

Lawrence + Memorial Hospital recognized as 2026 High Performing hospital for Maternity Care by U.S. News & World Report

New London, CT (Dec. 9, 2025) – Lawrence + Memorial Hospital (L+M) has been named a 2026 High Performing hospital for Maternity Care by U.S. News & World Report.

12/8/2025

Yale New Haven Health and the Connecticut Department of Consumer Protection advise parents on how to shop safely this holiday season

New Haven, CT (November 25, 2025) – As the holiday shopping season begins, Yale New Haven Health and the Connecticut Department of Consumer Protection (DCP) are emphasizing the importance of toy safety and urging families to stay vigilant about counterfeit or hazardous children’s products.

12/2/2025

Lawrence + Memorial Hospital offers new procedure for atrial fibrillation

New London, CT (Dec. 1, 2025) – Cardiac electrophysiologists at Lawrence + Memorial (L+M) Hospital recently performed a new procedure to treat atrial fibrillation (AFib) – the most common abnormal heart rhythm (cardiac arrhythmia) and the second most common cardiac condition in the United States, affecting more than eight million people.